YOU ARE HERE > Home > News > 2018-2023 Global & French Pharma Markets

2018-2023 Global & French Pharma Markets

This abstract, available by clicking on this link:

1. Reviews international healthcare expenditure.

2. Estimates the likely evolution of the global and the French pharma markets by 2023.

3. Highlights R&D expenditures and key projects.

4. Analyses the top 30 pharma companies performance and strategy (e.g. portfolio, geographical coverage, M&A).

5. Proposes a SWOT analysis and a one-page strategic implications for pharma companies.